Wave Life Sciences (WVE) Return on Invested Capital (2016 - 2024)
Wave Life Sciences (WVE) has disclosed Return on Invested Capital for 10 consecutive years, with 7.57% as the latest value for Q2 2024.
- For Q2 2024, Return on Invested Capital fell 1074.0% year-over-year to 7.57%; the TTM value through Jun 2024 reached 7.57%, down 1074.0%, while the annual FY2023 figure was 24.61%, 134.0% down from the prior year.
- Return on Invested Capital hit 7.57% in Q2 2024 for Wave Life Sciences, down from 2.2% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 156.96% in Q4 2023 and bottomed at 11.73% in Q3 2022.
- Average Return on Invested Capital over 5 years is 7.95%, with a median of 2.2% recorded in 2024.
- Year-over-year, Return on Invested Capital surged 15037bps in 2023 and then plummeted -1074bps in 2024.
- Wave Life Sciences' Return on Invested Capital stood at 1.6% in 2020, then crashed by -155bps to 4.06% in 2021, then surged by 262bps to 6.59% in 2022, then soared by 2283bps to 156.96% in 2023, then tumbled by -105bps to 7.57% in 2024.
- According to Business Quant data, Return on Invested Capital over the past three periods came in at 7.57%, 2.2%, and 156.96% for Q2 2024, Q1 2024, and Q4 2023 respectively.